ATP7B

CAMBRIDGE, Mass., July 23, 2026 Prime Medicine (Nasdaq: PRME) announced that the U.S. Food and Drug Administration (FDA) has...

CAMBRIDGE, Mass., June 18, 2026 Prime Medicine, Inc. announced that New Zealand’s Medicines and Medical Devices Safety Authority (Medsafe)...